| 2008 JASN IMPACT FACTOR 7.505 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Frontiers in Nephrology |
Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
Address correspondence to: Dr. J. Charles Jennette, Department of Pathology and Laboratory Medicine, 303 Brinkhous-Bullitt Building, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7525. Phone: 919-966-4676; Fax: 919-966-4542; E-mail: jcj{at}med.unc.edu
The reports of a newborn who developed glomerulonephritis and pulmonary hemorrhage after transplacental transfer of anti-neutrophil cytoplasmic antibody (ANCA) IgG with specificity for myeloperoxidase (MPO) is compelling clinical evidence that ANCA are pathogenic. In vitro studies indicate that ANCA activate cytokine-primed neutrophils and monocytes through both direct Fab'2 binding and Fc receptor engagement. Neutrophils that have been activated by ANCA release oxygen radicals, lytic enzymes, and inflammatory cytokines and adhere to and kill endothelial cells. A murine model caused by passive administration of mouse anti-mouse MPO IgG provides convincing evidence that ANCA IgG alone in the absence of antigen-specific T cells can cause necrotizing glomerulonephritis and vasculitis. This pathogenic process is enhanced by synergistic inflammatory factors, probably through priming of neutrophils. Immunization of rats with human MPO induces antibodies that cross-react with rat MPO and cause glomerulonephritis and vasculitis. These ANCA act in concert with chemokines to cause adherence of leukocytes to the walls of small vessels with subsequent injury. To date, animal models of disease that is induced by anti-proteinase 3 are less robust. Clinical and experimental data suggest but do not prove that the ANCA autoimmune response is initiated by an immune response to an antisense peptide of the ANCA antigen or its mimic that may be introduced into the body by an infectious pathogen. This antibody response elicits anti-idiotypic antibodies that cross-react with ANCA antigens. The pathogenesis of ANCA disease is multifactorial, with genetic and environmental factors influencing onset of the autoimmune response, the mediation of acute injury, and the induction of the chronic response to injury.
This article has been cited by other articles:
![]() |
J. A. Gomez-Puerta, J. Hernandez-Rodriguez, A. Lopez-Soto, and X. Bosch Antineutrophil Cytoplasmic Antibody-Associated Vasculitides and Respiratory Disease Chest, October 1, 2009; 136(4): 1101 - 1111. [Abstract] [Full Text] [PDF] |
||||
![]() |
B Terrier, D Saadoun, D Sene, P Ghillani, Z Amoura, G Deray, B Fautrel, J-C Piette, and P Cacoub Antimyeloperoxidase antibodies are a useful marker of disease activity in antineutrophil cytoplasmic antibody-associated vasculitides Ann Rheum Dis, October 1, 2009; 68(10): 1564 - 1571. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kumpers, J. Hellpap, S. David, R. Horn, H. Leitolf, H. Haller, and M. Haubitz Circulating angiopoietin-2 is a marker and potential mediator of endothelial cell detachment in ANCA-associated vasculitis with renal involvement Nephrol. Dial. Transplant., June 1, 2009; 24(6): 1845 - 1850. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Uriarte, K. R. McLeish, and R. A. Ward Anti-proteinase 3 antibodies both stimulate and prime human neutrophils Nephrol. Dial. Transplant., April 1, 2009; 24(4): 1150 - 1157. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Nasr, S. M. Said, A. M. Valeri, M. B. Stokes, N. N. Masani, V. D. D'Agati, and G. S. Markowitz Membranous Glomerulonephritis with ANCA-Associated Necrotizing and Crescentic Glomerulonephritis Clin. J. Am. Soc. Nephrol., February 1, 2009; 4(2): 299 - 308. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Erdbruegger, M. Grossheim, B. Hertel, K. Wyss, T. Kirsch, A. Woywodt, H. Haller, and M. Haubitz Diagnostic role of endothelial microparticles in vasculitis Rheumatology, December 1, 2008; 47(12): 1820 - 1825. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Nasr, V. D. D'Agati, H.-R. Park, P. L. Sterman, J. D. Goyzueta, R. M. Dressler, S. M. Hazlett, R. N. Pursell, C. Caputo, and G. S. Markowitz Necrotizing and Crescentic Lupus Nephritis with Antineutrophil Cytoplasmic Antibody Seropositivity Clin. J. Am. Soc. Nephrol., May 1, 2008; 3(3): 682 - 690. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Stassen, R. P. H. Derks, C. G. M. Kallenberg, and C. A. Stegeman Venous thromboembolism in ANCA-associated vasculitis--incidence and risk factors Rheumatology, April 1, 2008; 47(4): 530 - 534. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kantari, M. Pederzoli-Ribeil, O. Amir-Moazami, V. Gausson-Dorey, I. C. Moura, M.-C. Lecomte, M. Benhamou, and V. Witko-Sarsat Proteinase 3, the Wegener autoantigen, is externalized during neutrophil apoptosis: evidence for a functional association with phospholipid scramblase 1 and interference with macrophage phagocytosis Blood, December 1, 2007; 110(12): 4086 - 4095. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lionaki and R. J. Falk Removing Antibody and Preserving Glomeruli in ANCA Small-Vessel Vasculitis J. Am. Soc. Nephrol., July 1, 2007; 18(7): 1987 - 1989. [Full Text] [PDF] |
||||
![]() |
S. L. Hogan, G. S. Cooper, D. A. Savitz, L. A. Nylander-French, C. G. Parks, H. Chin, C. E. Jennette, S. Lionaki, J. C. Jennette, and R. J. Falk Association of Silica Exposure with Anti-Neutrophil Cytoplasmic Autoantibody Small-Vessel Vasculitis: A Population-Based, Case-Control Study Clin. J. Am. Soc. Nephrol., March 1, 2007; 2(2): 290 - 299. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Xiao, A. Schreiber, P. Heeringa, R. J. Falk, and J. C. Jennette Alternative Complement Pathway in the Pathogenesis of Disease Mediated by Anti-Neutrophil Cytoplasmic Autoantibodies Am. J. Pathol., January 1, 2007; 170(1): 52 - 64. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Schreiber, H. Xiao, R. J. Falk, and J. C. Jennette Bone Marrow-Derived Cells Are Sufficient and Necessary Targets to Mediate Glomerulonephritis and Vasculitis Induced by Anti-Myeloperoxidase Antibodies J. Am. Soc. Nephrol., December 1, 2006; 17(12): 3355 - 3364. [Abstract] [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2009 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673